July 31, 2023
RegMed Investors’ (RMi) closing bell: July ends on high note while sector LPS (loss-per-share) earnings are about to start
July 28, 2023
RegMed Investors’ (RMi) closing bell: algorithmic enhancement drives upside after downward spiral
July 27, 2023
RegMed Investors’ (RMi) closing bell: can share pricing slides be cured?
July 26, 2023
RegMed Investors’ (RMi) closing bell: Sector appreciates but, will it be harder to raise capital?
July 25, 2023
RegMed Investors’ (RMi) closing bell: softening outlook
July 24, 2023
RegMed Investors’ (RMi) closing bell: a snap, crackle and NO pop with blood on the walls following a big sector fall
July 12, 2023
RegMed Investors’ (RMi) closing bell: an upside theatre
July 11, 2023
RegMed Investors’ (RMi) closing bell: caution seems to be the sector’s word for the session
July 10, 2023
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector regains some altitude
July 7, 2023
RegMed Investors’ (RMi) closing bell: old uncle algorithms came to visit
June 30, 2023
RegMed Investors’ (RMi) closing bell: the oxygen machine was turned back on so the sector could climb the wall of worry
June 29, 2023
RegMed Investors’ (RMi) closing bell: a stress test of cell and gene therapy sector defines its equities
June 28, 2023
RegMed Investors’ (RMi) closing bell: it ain’t over, sentiment is testing resistance
June 27, 2023
RegMed Investors’ (RMi) closing bell: I told you yesterday, the cell and gene therapy sector would come back
June 26, 2023
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector gets ditched again
June 20, 2023
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector is back to the upside as market cools
June 16, 2023
RegMed Investors’ (RMi) closing bell: an intense week
June 15, 2023
RegMed Investors’ (RMi) closing bell: sector rises as jobless claims were flat
June 14, 2023
RegMed Investors’ (RMi) closing bell: the upside emptied on pessimism re share pricing
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.